🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 20 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/07/2007 17,34 17,52 16,98 16,98 -1,05% 3,11% 53.333
13/07/2007 17,22 17,64 16,80 17,16 -0,35% 4,88% 66.983
12/07/2007 18,00 18,06 16,98 17,22 -3,69% 6,00% 100.067
11/07/2007 17,70 18,48 17,46 17,88 +1,71% 5,76% 103.400
10/07/2007 18,06 18,12 17,10 17,58 -4,25% 5,65% 117.500
09/07/2007 17,28 18,60 17,04 18,36 +6,99% 9,03% 230.833
06/07/2007 16,92 17,28 16,62 17,16 +1,78% 3,90% 116.483
05/07/2007 16,80 17,22 16,62 16,86 -2,09% 3,57% 74.567
03/07/2007 16,68 17,28 16,50 17,22 +2,50% 4,68% 40.967
02/07/2007 16,80 17,04 16,68 16,80 +0,00% 2,14% 64.133
29/06/2007 17,04 17,04 16,50 16,80 -1,75% 3,17% 69.133
28/06/2007 16,92 17,22 16,86 17,10 +1,06% 2,13% 49.633
27/06/2007 16,98 17,40 16,86 16,92 -2,08% 3,18% 60.200
26/06/2007 17,34 17,76 17,10 17,28 -0,35% 3,81% 55.233
25/06/2007 17,82 18,06 17,10 17,34 -3,02% 5,39% 107.433
22/06/2007 17,64 17,88 17,16 17,88 +1,02% 4,08% 771.183
21/06/2007 17,58 17,70 17,16 17,70 -0,34% 3,07% 78.617
20/06/2007 17,94 18,00 17,58 17,76 -1,00% 2,34% 38.317
19/06/2007 18,12 18,24 17,64 17,94 -2,29% 3,31% 59.150
18/06/2007 17,94 18,36 17,10 18,36 +2,34% 7,02% 73.650
15/06/2007 18,54 18,54 17,58 17,94 +2,40% 5,18% 92.500
14/06/2007 17,34 17,70 17,10 17,52 +1,04% 3,46% 53.250
13/06/2007 17,34 17,40 16,80 17,34 +0,35% 3,46% 63.133
12/06/2007 18,12 18,24 17,22 17,28 -5,57% 5,63% 65.950
11/06/2007 17,04 18,84 16,92 18,30 +7,77% 11,27% 116.417
08/06/2007 16,62 17,28 16,50 16,98 +2,17% 4,69% 62.767
07/06/2007 16,92 17,10 16,56 16,62 -2,81% 3,19% 56.867
06/06/2007 16,86 17,22 16,50 17,10 +0,71% 4,27% 67.667
05/06/2007 17,22 17,40 16,92 16,98 -2,41% 2,79% 51.567
04/06/2007 18,42 18,42 17,40 17,40 -5,54% 5,54% 58.683